This article provides a critical appraisal of the available evidence concerning clinical
exposure to orally administered cannabidiol (CBD), with special reference to factors …

Cannabidiol (CBD) is a non-psychoactive phytocannabinoid known for its beneficial effects
including antioxidant and anti-inflammatory properties. Moreover, CBD is a compound with …

Alzheimer's disease (AD), considered the most common type of dementia, is characterized
by a progressive loss of memory, visuospatial, language and complex cognitive abilities. In …

The two main phytocannabinoids—delta-9-tetrahydrocannabinol (THC) and cannabidiol
(CBD)—have been extensively studied, and it has been shown that THC can induce …

Cannabidiol (CBD) is known for its vasorelaxant (including in the human pulmonary artery),
anti-proliferative and anti-inflammatory properties. The aim of our study was to examine the …

The hypothesis of this study was that we can modify the essential oil (EO) profile of hemp
(Cannabis sativa L.) and obtain fractions with differential composition and antimicrobial …

Inflammatory bowel diseases (IBD) are characterized by a chronic and recurrent
gastrointestinal condition, including mainly ulcerative colitis (UC) and Crohn's disease (CD) …

With the improvement in modern medicine, the world's human and feline (Felis catus, the
domestic cat) population is aging. As the population grows older, there is an increase of age …

Central Nervous System (CNS) disorders affect millions of people worldwide (Feigin et al.,
2019). Despite their growing impact on health systems and the urgent need for new, safer …

Introduction The use of cannabis and its derivatives have increased steadily over the past
few decades, prompting patients and clinicians to increasingly inquire about its health …